SRPT
Sarepta Therapeutics Inc
19.00$
-8.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 964.5% | 11,667.5% | 2.4% | 4.8% | 11.4% | 14.9% | 11.7% | 13.8% | 15.0% | 12.1% | 16.8% | 40.1% | |
| -864.5% | 100.0% | 97.6% | 95.2% | 88.6% | 85.1% | 88.3% | 86.2% | 85.0% | 87.9% | 83.2% | 59.9% | |
| 965.8% | 11,683.5% | 3,473.0% | 107.8% | 133.5% | 147.3% | 133.7% | 109.9% | 94.0% | 70.6% | 42.3% | 69.2% | |
| 505.4% | 5,989.1% | 1,497.9% | 77.5% | 69.8% | 74.8% | 58.9% | 40.3% | 48.4% | 38.8% | 29.3% | 21.8% | |
| 1,471.2% | 17,672.5% | 5,017.9% | 187.9% | 202.8% | 270.4% | 192.7% | 151.7% | 142.5% | 109.4% | 71.8% | 89.8% | |
| -1,371.2% | -17,572.5% | -4,920.3% | -111.0% | -114.1% | -185.3% | -104.5% | -65.5% | -57.5% | -21.5% | 11.5% | -29.9% | |
| 0.0% | 108.9% | 9.9% | 3.7% | 11.2% | 8.1% | 11.1% | 9.1% | 5.7% | 1.8% | 1.0% | 0.4% | |
| -1,391.7% | -17,560.3% | -4,930.2% | -31.5% | -120.5% | -187.5% | -102.4% | -59.7% | -73.9% | -41.8% | 13.7% | -31.9% | |
| -17.3% | -418.8% | -140.6% | 1.3% | -0.2% | 0.3% | 0.2% | 0.0% | 1.4% | 1.3% | 1.3% | 0.5% | |
| -1,391.7% | -17,560.3% | -4,930.2% | -32.8% | -120.2% | -187.8% | -102.6% | -59.7% | -75.4% | -43.1% | 12.4% | -32.5% | |
| -1,332.1% | -17,153.8% | -4,816.8% | -22.5% | -105.2% | -173.0% | -83.9% | -45.2% | -63.8% | -36.5% | 16.7% | -29.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.